These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33092235)

  • 61. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
    BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
    Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
    Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer.
    Wang Y; Guo L; Feng L; Zhang W; Xiao T; Di X; Chen G; Zhang K
    Oncol Rep; 2018 May; 39(5):2147-2159. PubMed ID: 29565466
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Independent Correlation Between Ki67 Index and Circulating Tumor Cells in the Diagnosis of Colorectal Cancer.
    Yang Y; Li J; Jin L; Wang D; Zhang J; Wang J; Zhao X; Wu G; Yao H; Zhang Z
    Anticancer Res; 2017 Aug; 37(8):4693-4700. PubMed ID: 28739773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
    Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
    Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Simultaneous phenotypic and genetic characterization of single circulating tumor cells from colon cancer patients.
    Campos M; Luque R; Jiménez J; Martínez R; Warleta F; Sánchez-Quesada C; Delgado-Rodríguez M; Calvo A; Gaforio JJ
    Histol Histopathol; 2013 Nov; 28(11):1439-50. PubMed ID: 23653253
    [TBL] [Abstract][Full Text] [Related]  

  • 68. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
    Mostert B; Jiang Y; Sieuwerts AM; Wang H; Bolt-de Vries J; Biermann K; Kraan J; Lalmahomed Z; van Galen A; de Weerd V; van der Spoel P; Ramírez-Moreno R; Verhoef C; Ijzermans JN; Wang Y; Gratama JW; Foekens JA; Sleijfer S; Martens JW
    Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Practical utility of circulating tumour cells as biomarkers in cancer chemotherapy for advanced colorectal cancer.
    Otsuka K; Imai H; Soeda H; Komine K; Ishioka C; Shibata H
    Anticancer Res; 2013 Feb; 33(2):625-9. PubMed ID: 23393358
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients.
    Lin CC; Yang CY; Hung TC; Wang CH; Wei SW; Schiro P; Tseng JY; Lin CH; Jiang JK
    Sci Rep; 2023 Mar; 13(1):4773. PubMed ID: 36959311
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®.
    Gorges TM; Stein A; Quidde J; Hauch S; Röck K; Riethdorf S; Joosse SA; Pantel K
    PLoS One; 2016; 11(5):e0155126. PubMed ID: 27182774
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in
    Grillet F; Bayet E; Villeronce O; Zappia L; Lagerqvist EL; Lunke S; Charafe-Jauffret E; Pham K; Molck C; Rolland N; Bourgaux JF; Prudhomme M; Philippe C; Bravo S; Boyer JC; Canterel-Thouennon L; Taylor GR; Hsu A; Pascussi JM; Hollande F; Pannequin J
    Gut; 2017 Oct; 66(10):1802-1810. PubMed ID: 27456153
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Colorectal Cancer CTCs Detection Using Two FCM Protocol Approaches.
    Mourtzikou A; Stamouli M; Karakitsos P; Athanasas G
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.
    Sastre J; Maestro ML; Puente J; Veganzones S; Alfonso R; Rafael S; García-Saenz JA; Vidaurreta M; Martín M; Arroyo M; Sanz-Casla MT; Díaz-Rubio E
    Ann Oncol; 2008 May; 19(5):935-8. PubMed ID: 18212090
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tumour heterogeneity and metastasis at single-cell resolution.
    Lawson DA; Kessenbrock K; Davis RT; Pervolarakis N; Werb Z
    Nat Cell Biol; 2018 Dec; 20(12):1349-1360. PubMed ID: 30482943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.